Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Park Inn by Radisson Amsterdam City West

Nov 17, 2026 1:30 PM - Nov 17, 2026 5:30 PM

La Guardiaweg 59, 1043 DE Amsterdam, Netherlands

Globalisation of the Pharmacovigilance System Master File (PSMF)

Pre-Conference Workshops Available as Separate Registration

Instructors

Willemijn  van der Spuij, MSc

Willemijn van der Spuij, MSc

Executive Director Europe | International - Patient Safety, Bristol Myers Squibb, Switzerland

Willemijn is the Executive Director Europe in the WorldWide Patient Safety Organisation in Bristol Myers Squibb. She is responsible for Patient Safety in the European region, including the Balkans, Baltics and distributor markets. Prior to this role she was responsible for the European markets, PV Intelligence & International Operations including the PSMF as well as Training and Outsourcing activities. Willemijn holds a Nursing Degree from the Netherlands, a BA (Hons) in Sociology from Goldsmiths college, University of London, UK and an MSc in Pharmacovigilance from the University of Hertfordshire, UK. Willemijn is co-chair of the EFPIA Pharmacovigilance Expert Working Group and Chair of the EFPIA International Pharmacovigilance Group.

Dionne  Usher

Dionne Usher

Associate Director, Office of the EU QPPV, Merck Sharp & Dohme Limited, United Kingdom

Dionne is based in the UK and works in MSD's Office of the Global Qualified Person for Pharmacovigilance (GQPPV). Dionne is MSD's PSMF Owner and supports various key Global/EU and UK QPPV projects and tasks, such as EudraVigilance access, audits and inspections support and general project management, as needed. As a member of various PSMF industry groups, they share a keen interest in all things PSMF and the various approaches that companies take towards ensuring an efficient and compliant approach to PSMF management for the EEA, UK and globally.

Anastasia  Daskajiannis St John

Anastasia Daskajiannis St John

GPvP Inspector, Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Anastasia has been an GPvP inspector for 4 years, with 8 years in total spent at the UK Medicines Regulator. Her PV experience ranges from product information quality and safety variations, ICSR case processing, signal assessment and management, as well as governance.  Her academic background is in biochemistry, for which she obtained a BSc from the University of York.

Deola  Coker

Deola Coker

PV Excellence Director, QPPV Office, Astrazeneca, United Kingdom

Deola Coker is an accomplished pharmaceutical executive serving as the Pharmacovigilance (PV) Excellence Director within the QPPV Office at AstraZeneca in the United Kingdom. Based in London, Ms. Coker possesses extensive expertise in structural drug safety monitoring, international regulatory standard-setting, and global risk mitigation. She holds a Bachelor of Science in Pharmacology and a Postgraduate Diploma in Pharmacovigilance from the University of Hertfordshire. In her senior leadership capacity, she drives global structural optimization and ensures that AstraZeneca's drug safety frameworks strictly align with evolving international health authority mandates

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.